Estradiol Other names: Oestradiol

Chemical formula: C₁₈H₂₄O₂ Molecular mass: 272.382 g/mol PubChem compound: 5757

Therapeutic indications

Estradiol is indicated for:

Indication

Population group: women, only adults (18 years old or older)

at least one of

Postmenopausal osteoporosis with pathological fracture
Postmenopausal osteoporosis
Menopausal and other perimenopausal disorders

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1

Atrophic vaginitis in menopause

Population group: only adults (18 - 65 years old)

Treatment for atrophic vaginitis, (due to oestrogen deficiency) in postmenopausal women.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

2.0 mg once every 3 months

Oestrogen deficiency symptoms in menopause

Population group: women, only adults (18 - 65 years old)

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.39 mg once every 3 days

Vasomotor symptoms associated with the menopause

Population group: women, only adults (18 - 65 years old)

Estradiol is indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1-2 mg once daily

Hypoestrogenism due to hypogonadism, castration, primary ovarian failure

Population group: only adults (18 - 65 years old)

Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1-2 mg once daily

Androgen-dependent carcinoma of the prostate

Population group: only adults (18 - 65 years old)

Treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

3-6 mg in 3 divided doses daily

Prevention of osteoporosis

Population group: only adults (18 - 65 years old)

When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1-2 mg once daily

Contraindications

Estradiol is contraindicated in the following cases:

Contraindication

at least one of

Malignant neoplasm of breast
Malignant neoplasms of female genital organs
Genitourinary tract hemorrhage
Lactation
Thromboembolic disorder
Cardiac failure
Pregnancy
Renal failure
Hepatic insufficiency
Hereditary erythropoietic porphyria
Porphyria cutanea tarda
Other porphyria

Pregnancy

Pregnancy

Lactation

Lactation

Porphyria

Porphyria

Oestrogen-dependent malignant tumours

Primary malignant neoplasm of endometrium

Genital bleeding

Genitourinary tract hemorrhage

Venous thromboembolism

at least one of

Thromboembolism of vein
Venous thrombosis
Pulmonary embolism

Thrombophilic disorders

Thrombophilia

Arterial thromboembolic disease, angina, myocardial infarction

at least one of

Arterial embolic and thrombotic occlusion
Angina
Myocardial infarction

Liver disease

at least one of

Hepatopathy
Hepatic insufficiency

Hypersensitivity to estradiol

Oestradiol allergy

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈